Severe veno-occlusive disease (VOD) of the liver is a leading cause of mortality after bone marrow transplantation (BMT). Vascular and parenchymal injuries account for acute portal hypertension and liver failure is frequently present. We describe the results of transjugular intrahepatic portosystemic shunt (TIPS) for the management of VOD after BMT. TIPS was performed in 10 patients with histologically proven severe VOD. Portal hypertension was controlled by TIPS in all patients (mean hepatic venous pressure gradient before, 20 ؎ 11 vs 6 ؎ 5 mm Hg after TIPS, P Ͻ 0.01) without technical complications. Five patients with rapidly worsening VOD died within 10 days of TIPS without any improvement. The five remaining patients with less advanced disease showed improvement in various clinical and biological parameters. Four patients subsequently died. The lone survivor continues to do well with resolution of VOD 6 months after TIPS. TIPS can be performed safely and controls portal hypertension in VOD after BMT. Arguments from the present series and from eight previously reported cases favour earlier application of TIPS to obtain improved overall survival. Bone Marrow Transplantation (2000) 25, 987-992. Keywords: veno-occlusive disease of the liver; bone marrow transplantation; transjugular intrahepatic portosystemic shunt Veno-occlusive disease (VOD) of the liver complicates bone marrow transplantation (BMT) in 1-2% to 64% of cases depending on the intensity of conditioning regimens, individual pharmacokinetic metabolism of antineoplastic drugs, indication for transplantation, type of marrow donor, and certain risk factors such as pretransplant hepatitis and fever (for review see Ref. 1). VOD post BMT is the main cause of dose-limiting toxicity in high-dose radio-chemotherapy conditioning regimens for BMT, and subsequently one of the three leading causes of transplantation-related death together with graft-versus-host disease and infections in bone marrow recipients.
mately 30 000 patients per year undergo BMT for malignancy. An estimated 5000 of them will develop VOD, and approximately 1200 will die from this complication. Venoocclusive disease of the liver is characterized by concentric narrowing of terminal hepatic venules and small sublobular veins. In the acute form there is centrilobular congestion and necrosis. 3 This injury of zone 3 of the liver acinus 4 produces the clinical syndrome characterized by the combination of acute portal hypertension with hepatomegaly, ascites, right upper quadrant abdominal pain and acute liver failure with coagulopathy and encephalopathy. Jaundice and cytolysis reflect liver parenchyma injury subsequent to liver congestion. Despite aggressive treatments, including the combination of tissue plasminogen activator (t-PA) and heparin, severe VOD is almost uniformly fatal. 5 Given the lack of acceptable therapies, it seems reasonable to consider portal decompression in patients with life-threatening venoocclusive disease. We report here our preliminary experience with TIPS for severe VOD following BMT. 6 as the development after BMT of two of the following: (1) bilirubin у34 mol/l (у2 mg/dl), (2) weight gain у2.5% from pretransplant baseline, and (3) hepatomegaly and/or right upper quadrant pain, only if no other cause of liver disease was identified by studies including viral serology and abdominal Doppler ultrasonography.
Materials and methods

Clinical diagnosis
VOD was defined according to McDonald et al
Histological diagnosis
All histological specimens were obtained via the transjugular route and were examined by the same pathologist. 7, 8 Histological diagnosis of VOD was based on previously published criteria, ie occlusion of terminal hepatic venules, sinusoidal congestion, centrizonal hemorrhagic necrosis, and sinusoidal fibrosis. 4 Hepatic venous pressures were not measured during this procedure.
TIPS procedure and follow-up
TIPS was performed as a separate procedure from transjugular liver biopsy, after liver histology had been reviewed. The technique of TIPS has already been reported elsewhere in detail. 9 At the time of TIPS, hepatic venous and portal vein pressures were measured before and after TIPS and the hepatic venous pressure gradient (HVPG) was calculated (hepatic venous pressure gradient = portal pressure − hepatic venous pressure, mm Hg). All patients were managed on an emergency basis, ie TIPS were performed within 24 h of admission to our center and diagnosis of probably irreversible VOD.
Written consent according to the ethical guidelines of our institution, was obtained from all patients or their family as appropriate. After the TIPS procedure, patients were followed-up with serial laboratory studies and Doppler ultrasonography according to our protocol. 10 None of the patients had post-TIPS catheterization of the shunt.
Data analysis
Because several of the variables studied had extreme outlier values, results are given as mean Ϯ standard deviation and as range and median unless otherwise stated. Statistical analysis was performed as indicated with a statistical analysis program package (StatView 4.5 software (Abacus Concepts, Berkeley, CA, USA)).
Results
Since 1993, 10 consecutive patients have been sent to our Hepato-Biliary Center (Villejuif, France) from four centers of BMT for management of suspected severe VOD following BMT for malignancy. One of these patients has already been reported. 11 Diagnosis of VOD was clinical and confirmed by emergency transjugular liver biopsy in all cases.
According to the criteria of Bearman et al, 5 all patients had life-threatening severe VOD following BMT. The main clinical and biological characteristics of the 10 patients are summarized in Table 1 . There were eight men and two women aged from 11 to 52 years (mean = 31.3 Ϯ 12.5, median = 32 years). Two patients had autologous BMT, and eight had allogeneic BMT; all the latter but one had complete HLA matching. The conditioning regimens All allogeneic BMT were with complete HLA-matching except patient 1 (mismatch DR, DQ). Cy = cyclophosphamide; Mi = misulban; Th = thiotepa; Me = melphalan; Car = carboplatin; Bu = busulphan.
( Table 1) varied and included total body irradiation in 6/10 patients. Before BMT, serology for viruses A, B and C was negative in all but two patients who were positive for virus C antibodies. Prior to BMT, 9/10 patients had transaminases (ALT) within the normal range (0-43 IU/l) and one patient had elevated transaminases (63 IU/l).
Pre-TIPS
Clinically detectable ascitis was present in all patients, six of whom required paracentesis prior to TIPS for symptomatic relief. One of the latter had combined bilateral pleural drainage. All patients but one were jaundiced with bilirubin values ranging from 9 to 614 mol/l (mean = 206 Ϯ 178, median = 158 mol/l). Prothrombin time (Quick index) ranged from 30% to 94% of normal level (normal Ͼ60%) (mean = 50 Ϯ 20, median = 45%). Eight patients were oliguric or anuric at the time of TIPS but none was on hemodialysis prior to TIPS. Engraftment was present in seven patients and absent in three.
TIPS
TIPS was successfully performed without technical complications in all 10 cases; at a mean of 53 Ϯ 65 days (range: 12-227, median = 25 days) after BMT and 35 Ϯ 53 days (range: 6-182, median = 18 days) after the first sign of VOD. The portal vein flow was hepatofugal in 6/10 patients and hepatopedal in all patients prior to and after TIPS, respectively. The hepatic venous pressure gradient dropped from 20 Ϯ 11 mm Hg (range: 8-40, median = 22 mm Hg) to 6 Ϯ 5 mm Hg (range: 2-17, median = 5 mm Hg) (P Ͻ 0.01, paired t-test). The main hemodynamic parameters and outcome of the 10 patients are summarized in Table 2 .
Post TIPS
Five patients died of multiple organ failure (MOF) within 10 days of TIPS without any improvement (patients 1, 2, 4, 5, 9). The MOF was associated with infection in the three patients who had no engraftment at the time of TIPS.
TIPS for severe VOD of the liver after BMT D Azoulay et al 989 Table 2 Changes in hepatic venous pressure gradient and laboratory data within 2 weeks after TIPS Body weight gain was measured as follows (weight at TIPS − weight before BMT)/weight before BMT. HVG = hepatic venous pressure gradient; ALT = alanine aminotransferase; PT = prothombin time (% of normal level); N = normal; H = hemodialysis or hemodiafiltration.
Patient 9 had a splenectomy 2 days after TIPS for spontaneous rupture of a histologically proven splenic vascular malformation. All these five patients were anuric prior to TIPS and only two had had some urinary output (Ͻ100 ml/h until death) following TIPS. Table 3 shows the absence of improvement of biological parameters in these patients following TIPS. The delay between the first sign of VOD and the date of TIPS was shorter in these patients than in the five surviving for more than 10 days after TIPS (16 Ϯ 15 days (range: 6-40, median = 8 days) vs 56 Ϯ 72 days (range: 13-182; median = 19 days) but this did not reach statistical significance (P = 0.2, Mann-Whitney U test).
Five patients (patients 2, 6, 7, 8, 10) showed improvement in various parameters including a significant improvement in ALT and creatinine values (Table 3) . These patients seemed to have had less severe disease prior to TIPS (Table 3) . However, comparison of variables before TIPS between the two groups of patients did not reach statistical significance (Mann-Whitney U test). After TIPS, the group of patients surviving more than 10 days showed significantly improved creatinine (P = 0.03, Mann-Whitney U test) whereas improvement of bilirubin, ALT, PT and HVPG did not reach statistical significance (P = 0.2, 0.1, 0.06 and 0.5, respectively). Ascites was clinically decreased in all five patients and four of them with pre-TIPS anuria (two cases) or oliguria (two cases) had post-operative improved urinary output. None required post-TIPS hemodialysis. Three of these five patients (patients 2, 7, 8) died during the same hospitalization more than 10 days after Bone Marrow Transplantation TIPS (day 11, day 14 and day 25) from respiratory complications (Table 2 ) and two patients were discharged from hospital 9 days and 37 days after TIPS. One of the latter patients died on day 54 of fulminant cytomegalovirus pneumopathy. 11 One patient is currently alive and at home 6 months after TIPS with normal liver and renal function. All nine patients who died had patent TIPS on Doppler examination until death. Autopsy was performed in three cases and confirmed TIPS patency.
Discussion
VOD shares with the Budd-Chiari syndrome the same rationale for porta-caval decompression using the portal vein as an outflow tract: the hepatic artery vascularizes the sinusoids and then flows retrograde into the vena cava via the portal vein.
12-14 Surgical porta-caval shunts have been applied in very few patients with severe VOD after BMT because these patients are usually not acceptable candidates for surgery. 15, 16 Compared to surgical porta-caval shunts, TIPS may be performed without laparotomy which is associated with the risks of infection in an immunocompromised patient and bleeding due to the coagulopathy. In addition, TIPS reduces the operative stress and the tissue trauma to a minimum.
Excluding the one case reported from our center 11 and included in the present series, eight cases of TIPS for severe VOD after BMT have been reported so far. [17] [18] [19] TIPS could be performed without technical complications and con- Table 3 Biological and hemodynamical parameters before and after TIPS in five patients deceased within 10 days of TIPS without any improvement vs five patients with post-TIPS improvement and surviving more than 10 days Values were taken the day of TIPS and the less deranged one within 2 weeks of TIPS. Pre-TIPS values were not statistically different in the two groups of patients surviving Ͻ or Ͼ10 days after TIPS. After TIPS, the only significant improvement occurred for creatinine when comparing the two groups of patients (P = 0.03). Results are given mean ± standard deviation (range, median). TIPS = transjugular intrahepatic portosystemic shunt; ALT = alanine aminotransferase; HVPG = hepatic venous pressure gradient; ⌬ HVPG = variation of HVPG.
trolled portal hypertension in all cases. The 18 cases of TIPS for VOD after BMT now available for analysis could be divided into two groups according to the outcome following TIPS. In one group of patients (8/18 cases), TIPS was not followed by any marked improvement in the patients condition and all died after a delay ranging from 2 days to 13 days after TIPS (median = 8 days) despite controlled portal hypertension. The pathophysiology of VOD after BMT is beyond the scope of this paper, however, once again this strongly suggests that the clinical manifestations of severe VOD do not solely result from portal hypertension. 1, 3 In this group of patients with an invariably fatal outcome, continued medical care may be questionable. On an individual basis we decided however to keep performing TIPS in these patients despite all reported failures as a salvage procedure.
In a second subset of patients (10/18 cases) TIPS was followed by a significant improvement in various parameters. This improvement was transient (seven cases) and followed by death with a delay ranging from 11 to 57 days after TIPS (median = 25 days) significantly longer than for patients who died without improvement (P = 0.01, MannWhitney) 18, 19 (Table 2) . Three patients can be considered long-term survivors at 6 months (updated), 6 months and 9 months (Table 2) . 17, 19 The absence of statistical significance with regard to improvement in bilirubin, ALT, PT, and HVPG when comparing patients surviving with those not surviving more than 10 days, may be due to sample size.
If TIPS is to be successful, it should be performed as early as possible, before multiorgan failure is triggered. Models for predicting fatal outcome from VOD after BMT 5 might be useful and support a need to proceed sooner with TIPS. The trend towards a shorter delay between onset of VOD and TIPS in patients dying within 10 days of TIPS compared to those surviving Ͼ10 days, suggests a faster pace of the disease for the former. Considering the spontaneous outcome of severe VOD following BMT, it is highly improbable that patients surviving more than 10 days after TIPS would have had spontaneous recovery from VOD. However, only a prospective randomized study could formally prove this hypothesis.
Considering the transient nature of the improvement of many patients after TIPS, this might still be used as a measure 'to tide the patient over' until he recovers, in addition to other treatments, 21 or other definitive measures such as liver transplantation become applicable. Liver transplantation has the advantage, as obvious as theoretical, over other methods of treatment for VOD post BMT in the dramatic and complete correction of the liver problem. This has been reported in nine cases. [22] [23] [24] [25] [26] [27] [28] Two patients were both alive 9 months after liver transplantation, with normal liver function. All seven remaining patients died, mainly from infection. When hepatic failure prevents an otherwise successful outcome to BMT, TIPS may be considered as a bridge to liver transplantation to ameliorate the degree of hepatic and renal dysfunction, until a liver graft is available and to improve the outcome of liver transplantation as a result of improved perioperative renal function and general status. 29, 30 This strategy was recently applied with success in a case of fulminant Budd-Chiari syndrome. 31 In conclusion, TIPS can be performed safely and controls portal hypertension in patients with severe VOD after BMT. Long-term survival can be obtained in a small number of patients. The actual indications and particularly the timing of TIPS remain to be established to obtain survival benefits in most patients who at best so far have a transient improvement. We are conscious that the comments of the present series must be taken with a note of caution.
